Latest filing published 15 Oct 2020 for Arvinas, INC..
Insider track record
Canaan IX L.P.: trading record in brief
This profile gathers the share dealings of Canaan IX L.P. across 3 companies, led by CytomX Therapeutics, Inc., TheRealReal, Inc. and Arvinas, Inc. We count 45 filings; the first trade dates from 14 October 2015 and the latest from 14 October 2020.
Every open-market trade on record is a sale: 29 sales worth €6.3M.
The newest entry dates from 15 October 2020: a transaction, in Arvinas, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Canaan IX L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 400,000 sharesCommon StockSEC:0000899243-20-028308:0
- 500,000 sharesCommon StockSEC:0000899243-20-019796:0
- 881,000 sharesCommon StockSEC:0000899243-20-001324:0
- 3,699,136 sharesCommon StockSEC:0000899243-19-018885:0
- 1,107,412 sharesCommon StockSEC:0000899243-19-018885:1
- 2,060,411 sharesCommon StockSEC:0000899243-19-018885:2
- 895,290 sharesCommon StockSEC:0000899243-19-018885:3
- 327,149 sharesCommon StockSEC:0000899243-19-018885:4
- 213,510 sharesCommon StockSEC:0000899243-19-018885:5
- 500,000 sharesCommon StockSEC:0000899243-19-016634:0
- 4,989,554 sharesCommon StockSEC:0000899243-18-026089:0
- 750,000 sharesCommon StockSEC:0000899243-17-008751:0
- 400,000 sharesCommon StockSEC:0000899243-16-034627:1
- 22,086 shares@ US$11.18393.7% of flowCommon StockSEC:0000899243-16-034627:0
- 10,890 shares@ US$11.83851.9% of flowCommon StockSEC:0000899243-16-034442:0
- 6,729 shares@ US$11.79091.2% of flowCommon StockSEC:0000899243-16-034442:1
- 20,840 shares@ US$11.33123.5% of flowCommon StockSEC:0000899243-16-034442:2
- 42,550 shares@ US$11.70577.4% of flowCommon StockSEC:0000899243-16-034194:0
- 12,805 shares@ US$11.64272.2% of flowCommon StockSEC:0000899243-16-034052:1
- 13,548 shares@ US$11.72022.4% of flowCommon StockSEC:0000899243-16-034052:2
- 18,971 shares@ US$11.50273.2% of flowCommon StockSEC:0000899243-16-034052:0
- 33,064 shares@ US$11.4775.6% of flowCommon StockSEC:0000899243-16-033704:0
- 18,517 shares@ US$11.55443.2% of flowCommon StockSEC:0000899243-16-033704:1
- 27,135 shares@ US$11.07024.4% of flowCommon StockSEC:0000899243-16-033335:0
- 35,391 shares@ US$11.20235.8% of flowCommon StockSEC:0000899243-16-033335:1
25 of 45 declarations
